Krystal Biotech, Inc. (KRYS)

NASDAQ: KRYS · Real-Time Price · USD

303.06

+2.18 (0.72%)

At close: Nov 9, 2026, 4:00 PM EST

306.56

+3.50 (1.15%)

Pre-market: Nov 10, 2026, 7:34 AM EST

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,981	7,149	4,506	3,499	2,040	1,742
Market Cap Growth	56.47%	58.67%	28.76%	71.56%	17.08%	47.34%
Enterprise Value	7,795	6,294	3,819	2,909	1,642	1,388
Last Close Price	303.06	246.54	156.66	124.06	79.22	69.95

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	41.17	34.90	50.54	320.10	-	-
Forward PE	35.00	34.89	33.31	-	-	-
PS Ratio	19.11	18.37	15.51	69.02	-	-
PB Ratio	6.26	5.86	4.76	4.49	3.91	2.94
P/TBV Ratio	6.26	5.86	4.76	4.49	3.91	2.94
P/FCF Ratio	28.96	37.84	37.81	-	-	-
P/OCF Ratio	27.72	35.59	36.51	-	-	-
PEG Ratio	0.98	0.61	-	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	16.58	16.18	13.15	57.38	-	-
EV/EBITDA Ratio	34.03	38.64	36.12	-	-	-
EV/EBIT Ratio	34.26	39.02	36.99	-	-	-
EV/FCF Ratio	25.14	33.32	32.04	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.02	0.01
Debt / EBITDA Ratio	0.04	0.06	0.07	-	-	-
Debt / FCF Ratio	0.03	0.05	0.06	-	-	-
Net Debt / Equity Ratio	-0.83	-0.78	-0.78	-0.75	-0.72	-0.83
Net Debt / EBITDA Ratio	-5.18	-5.81	-7.02	6.29	3.16	7.37
Net Debt / FCF Ratio	-3.82	-5.01	-6.23	5.83	2.44	4.25
Asset Turnover	0.33	0.33	0.31	0.07	-	-
Inventory Turnover	0.61	0.69	1.20	-	-	-
Quick Ratio	7.35	9.28	6.89	17.35	13.14	17.02
Current Ratio	7.89	9.95	7.28	17.77	13.30	17.18
Return on Equity (ROE)	17.50%	18.91%	10.34%	1.68%	-25.09%	-15.71%
Return on Assets (ROA)	10.06%	8.44%	6.89%	-8.82%	-12.80%	-9.32%
Return on Invested Capital (ROIC)	37.54%	42.60%	31.62%	-40.50%	-76.89%	-74.23%
Return on Capital Employed (ROCE)	15.80%	13.10%	10.80%	-12.40%	-22.90%	-11.60%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.43%	2.86%	1.98%	0.31%	-6.86%	-3.99%
FCF Yield	3.45%	2.64%	2.65%	-2.88%	-7.53%	-6.67%
Buyback Yield / Dilution	-2.44%	-0.71%	-7.16%	-8.87%	-14.85%	-18.15%

SEC Filings: 10-K · 10-Q